MALATO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 3.406
EU - Europa 2.759
AS - Asia 1.892
SA - Sud America 274
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 8.389
Nazione #
US - Stati Uniti d'America 3.368
SG - Singapore 694
IT - Italia 652
CN - Cina 530
RU - Federazione Russa 509
DE - Germania 390
FI - Finlandia 340
UA - Ucraina 285
BR - Brasile 208
HK - Hong Kong 185
VN - Vietnam 170
GB - Regno Unito 119
PL - Polonia 102
IE - Irlanda 94
SE - Svezia 90
FR - Francia 78
JP - Giappone 78
IN - India 49
KR - Corea 34
BE - Belgio 32
BD - Bangladesh 26
AR - Argentina 23
TR - Turchia 23
IQ - Iraq 20
CA - Canada 16
CI - Costa d'Avorio 15
MX - Messico 14
ZA - Sudafrica 14
NL - Olanda 12
RO - Romania 12
UZ - Uzbekistan 12
AT - Austria 11
IR - Iran 11
VE - Venezuela 11
ES - Italia 9
ID - Indonesia 9
MA - Marocco 9
EC - Ecuador 8
PK - Pakistan 8
CO - Colombia 7
PY - Paraguay 7
CL - Cile 6
SA - Arabia Saudita 6
EU - Europa 4
GR - Grecia 4
IL - Israele 4
KZ - Kazakistan 4
LT - Lituania 4
PH - Filippine 4
AL - Albania 3
BG - Bulgaria 3
CH - Svizzera 3
DZ - Algeria 3
EG - Egitto 3
KE - Kenya 3
QA - Qatar 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
JM - Giamaica 2
JO - Giordania 2
MD - Moldavia 2
MY - Malesia 2
NP - Nepal 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
MM - Myanmar 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 8.389
Città #
Ashburn 475
Singapore 464
Fairfield 261
Chandler 244
San Jose 182
Woodbridge 182
Hong Kong 177
Ann Arbor 160
Wilmington 159
Jacksonville 151
Houston 135
Palermo 119
Seattle 101
Dublin 93
Frankfurt am Main 90
Zgierz 89
Cambridge 88
Beijing 86
Moscow 79
Tokyo 77
Medford 68
Nanjing 66
Ho Chi Minh City 58
Des Moines 54
Santa Clara 54
New York 53
Los Angeles 48
Princeton 45
Dearborn 42
Hanoi 42
Hefei 38
Tulsa 38
Boardman 36
Altamura 34
The Dalles 33
Council Bluffs 32
Lauterbourg 31
Brussels 30
Helsinki 26
Lawrence 26
Orem 25
São Paulo 22
Dallas 20
Nanchang 20
Shenyang 20
Tianjin 20
Milan 19
Buffalo 18
San Diego 18
Jinan 16
Regensburg 16
Abidjan 15
Stockholm 15
Bremen 14
Changsha 14
Seongnam 14
Kumar 13
Hebei 12
Izmir 12
Ludwigshafen am Rhein 12
Chicago 11
Denver 11
Rome 11
Verona 11
Zhengzhou 11
Ningbo 10
San Mateo 10
Amsterdam 9
Columbus 9
Guangzhou 9
Jiaxing 9
London 9
Napoli 9
Nuremberg 9
Shanghai 9
Tehran 9
Warsaw 9
Auburn Hills 8
Brooklyn 8
Chennai 8
City of London 8
Poplar 8
Rio de Janeiro 8
Baghdad 7
Brasília 7
Haiphong 7
Hangzhou 7
Johannesburg 7
Kunming 7
Lanzhou 7
Phoenix 7
Turku 7
Cardiff 6
Haikou 6
Montreal 6
New Delhi 6
Taiyuan 6
Tashkent 6
Washington 6
Belo Horizonte 5
Totale 4.924
Nome #
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica 653
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. 340
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 313
Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin. 254
Successful Treatment of Gastrointestinal Bleeding With Recombinant Factor VIIa After Kidney Transplantation in Patients With Pancytopenia. 245
Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management 232
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study 225
The risk of recurrent cardiovascular events in patients with increased plasma homocysteine levels is reduced by short but not long-term therapy with folate and B vitamins. 214
Recurrent venous thromboembolism complicated by heparin-induced thrombocytopenia as a first manifestation of an occult cancer: a case report. 214
Peri-operative bridgning therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy 211
Deferral of assessment of pulmonary embolism 210
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis 204
Deep vein thrombosis and pulmonary embolism can be treated at home in cancer patients 203
Managing cancer patients with acute venous thromboembolism: exploring safe alternatives to hospitalisation 200
PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY 194
Persistance of residual vein thrombosis after an episode of deep vein thrombosis of the lower limbs and the risk of new cancer and cardiovascular disease. 193
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression Ultrasonography (DACUS) study 193
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS 189
Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study 186
La profilassi chirurgica di pazienti con carenza congenita di FVII 182
Gastrointestinal bleeding in patients with von Willebrand disease; how long we can wait for surgery? 178
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins 177
Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer. 170
The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease 166
Evaluation of patients with thrombotic stroke by methionine loading oral curve 161
Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. 157
THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE 156
The persistence of residual vein thrombosis, after an episode of deep vein thrombosis, and the risk of new overt cancer. 156
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. 155
ISAM: international study on anticoagulation management. The Italian experience 153
Uso del FVIIa ricombinante nell'emorragia gastrica post trapianto renale 151
Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk 151
Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial 151
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis 150
Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review. 147
Successful treatment of acquired haemophilia with FEIBA and Retuximab 146
Ultrasonography-guided central venous catheterisation in haematological patients with severe thrombocytopenia 145
Residual vein thrombosis assessment establishes the otpimal duration of oral anticoagulants in patients with idiopathic or provoked deep vein thrombosis 139
Optimal duration of antithrombotic therapy in carcer patients with deep vein thrombosis: the role of residual vein thrombosis. the cancer dacus 131
Residual vein thrombosis estabilishes the optimal duration of oral anticoagulants for the treatment od DVT 117
Thrombophilia in women with unexplained fetal loss 115
Residual Vein Thrombosis Assessment Establishes the Optimal Duration of Oral Anticoagulants in Patients with Idiopathic or Provoked Deep Vein Thrombosis: a Randomized, Controlled Trial 115
Residual vein thrombosis assessment estabilishes the optimal duration of oral anticoagulants in patients with idiopatic or provoked deep vein thrombosis. a randomized, controlled trial 108
Prognostic relevance of an asymptomatic venous thromboembolism in patients with cance 100
Un caso di emorragia gastrica post-trapianto di rene 97
Totale 8.447
Categoria #
all - tutte 25.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 0 0 0 0 64 68
2021/2022510 31 121 9 34 14 13 23 15 65 81 21 83
2022/2023670 67 107 16 92 83 107 36 52 68 2 31 9
2023/2024362 9 48 37 55 26 72 44 14 3 7 5 42
2024/2025699 23 29 5 81 41 16 44 32 48 72 114 194
2025/20262.998 224 104 167 273 338 450 329 288 191 564 70 0
Totale 8.447